Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis
NCT05176366
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class
Stopped
Enrollment challenges.
Conditions
Ulcerative Colitis
Inflammatory Bowel Diseases
Interventions
BIOLOGICAL:
ExoFlo
Sponsor
Direct Biologics, LLC